SUZHOU RIBO LIFE SCIENCE CO., LTD. Patent Application Trends in 2024
Revision as of 15:15, 19 October 2024 by Wikipatents (talk | contribs) (Updating SUZHOU RIBO LIFE SCIENCE CO., LTD._Patent_Application_Trends_in_2024)
Contents
SUZHOU RIBO LIFE SCIENCE CO., LTD. Patent Filing Activity
SUZHOU RIBO LIFE SCIENCE CO., LTD. patent applications in 2024
Top 10 Technology Areas
- C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants)
- A61P3/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- C12N2310/321 (2'-O-R Modification)
- C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids})
- C12N2310/322 (2'-R Modification)
- A61K47/54 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61P31/20 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- C12N15/1131 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants)
Emerging Technology Areas
- A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- C12N2310/31 (of the backbone)
- A61P19/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61K47/543 ({Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine})
- C12N15/1137 ({against enzymes (viral enzymes)
- C12N2310/315 (of the backbone)
- A61P31/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- C12N15/1131 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants)
- A61P31/20 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
Top Inventors
- Hongyan ZHANG (4 patents)
- Shan GAO (4 patents)
- Zicai LIANG (2 patents)
- Haitao LI (2 patents)
- Daiwu KANG (2 patents)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
SUZHOU RIBO LIFE SCIENCE CO., LTD. Inventor States 2024 - Up to September 2024
Categories:
- Pages with broken file links
- SUZHOU RIBO LIFE SCIENCE CO., LTD.
- Companies
- CPC C12N15/113
- CPC A61P3/06
- CPC A61P31/20
- CPC C12N15/1131
- CPC C12N2310/14
- CPC C12N2310/321
- CPC C12N2310/351
- CPC A61K47/549
- CPC A61P31/04
- CPC C12N2310/315
- CPC C12N2310/322
- CPC C12N15/1137
- CPC A61K47/54
- CPC A61K47/543
- CPC A61K47/545
- CPC A61P19/06
- CPC C12N2310/31
- CPC A61K31/713
- Patent Trends by Company in 2024
